Covestor’s Nurix Therapeutics NRIX Stock Holding History
Bought
Maintained
Sold
Other funds holding NRIX
BBA
Covestor's NRIX Position: Q3 2026 in Review
Covestor reduced its Nurix Therapeutics (NRIX) stake by 39% in Q3 2026, selling an estimated $299 and leaving 19 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #2680.
Covestor first reported a position in NRIX in Q4 2021 and has held it in 12 quarters since. The position peaked at $1K in Q2 2026. 233 funds tracked by Wall St. Rank hold NRIX as of Q3 2026.
- Covestor held 19 shares of Nurix Therapeutics worth $0 as of Q3 2026.
- Covestor sold 12 Nurix Therapeutics shares in Q3 2026, an estimated $299.
- Nurix Therapeutics made up ﹤0.01% of Covestor's portfolio in Q3 2026, its #2680 holding.
- Covestor first reported a position in Nurix Therapeutics in Q4 2021 and has held it in 12 quarters since.
- Covestor's Nurix Therapeutics position peaked at $1K in Q2 2026.
- 233 funds tracked by Wall St. Rank held Nurix Therapeutics as of Q3 2026.
Based on Covestor's 13F filing for Q3 2026, filed 30 Oct 2026.